000 01529 a2200421 4500
005 20250518030653.0
264 0 _c20190417
008 201904s 0 0 eng d
022 _a2213-0276
024 7 _a10.1016/j.lpm.2019.02.025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpringfeld, Christoph
245 0 0 _aChemotherapy for pancreatic cancer.
_h[electronic resource]
260 _bPresse medicale (Paris, France : 1983)
_cMar 2019
300 _ae159-e174 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAlgorithms
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAntineoplastic Agents, Immunological
_xtherapeutic use
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCarcinoma, Pancreatic Ductal
_xpathology
650 0 4 _aChemoradiotherapy, Adjuvant
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aNeoadjuvant Therapy
650 0 4 _aPancreatic Neoplasms
_xpathology
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aJäger, Dirk
700 1 _aBüchler, Markus W
700 1 _aStrobel, Oliver
700 1 _aHackert, Thilo
700 1 _aPalmer, Daniel H
700 1 _aNeoptolemos, John P
773 0 _tPresse medicale (Paris, France : 1983)
_gvol. 48
_gno. 3 Pt 2
_gp. e159-e174
856 4 0 _uhttps://doi.org/10.1016/j.lpm.2019.02.025
_zAvailable from publisher's website
999 _c29485775
_d29485775